Where does Accurate Medical Therapeutics Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Accurate Medical Therapeutics Ltd. ranks #27,968 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Accurate Medical Therapeutics Ltd. hold?

Accurate Medical Therapeutics Ltd. holds 9 US utility patents granted between 2019 and 2025, spanning 9 technology areas.

What is Accurate Medical Therapeutics Ltd.'s Innovation Score?

Accurate Medical Therapeutics Ltd. has an Innovation Score of 38.6 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Accurate Medical Therapeutics Ltd.'s patent grant rate increasing or decreasing?

Accurate Medical Therapeutics Ltd.'s recent grant velocity is +200% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Accurate Medical Therapeutics Ltd.'s patents?

Accurate Medical Therapeutics Ltd.'s patents average 14.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Accurate Medical Therapeutics Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Accurate Medical Therapeutics Ltd.

Q: What technology areas does Accurate Medical Therapeutics Ltd. focus on?

Accurate Medical Therapeutics Ltd.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 8 patents. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 9 granted patents across 9 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Accurate ranks #27,968 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 9 technology areas.

#27,968
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.6/100): 14.9
avg claims per patent: +200%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27968 · Foreign Corporation #27,968 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 9 grants
MID-PACK #27,968/49,997
PHOTO-FINISH Abclon
CPC-NARROW A61M · 9 areas
INNOV-THIN 38.6/100
CLAIMS-RICH 14.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +200% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Abclon Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Accurate Medical… · this assignee

39
3D Lighting… · lowest

7

What this shows Accurate's Innovation Score is 38.6/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Accurate's grants concentrate

Accurate Medical Therapeutics Ltd. is a focused PatentsView assignee: 9 CPC subclasses with 88.9% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2021. By volume, Accurate sits between Abclon Inc. and ACS Industries, Inc..

Accurate's three-year grant acceleration

Accurate Medical Therapeutics Ltd. shows 5 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Abclon

9
ABM Italia S P A

9
AC Avalanche

9
Acandis & KG

9
ACD

9
ACO Ahlmann SE &…

9
Acorn West

9
ACS Industries

9
Accurate Medical… ◀

9

What this shows Accurate holds 9 patents at rank #27,964, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Accurate

By rank, the assignees closest to #27,964 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Accurate's primary technology class.

Accurate's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Accurate Medical Therapeutics Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	2	22.2%
2021	1	11.1%
2022	2	22.2%
2023	1	11.1%
2024	2	22.2%
2025partial year	1	11.1%

Which technologies does Accurate Medical Therapeutics Ltd. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 8

A61B - DIAGNOSIS; SURGERY; Identification 7

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 5

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 1

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 1

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 1

Top 9 of 9 technology areas

Where it ranks

Overall rank by patents

#27,968

of 49,997 tracked assignees

Innovation Score

38.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Accurate Medical Therapeutics Ltd.'s patent record in context - here's where to go next.

Accurate Medical Therapeutics Ltd.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 88.9% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #27,968 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Accurate Medical Therapeutics Ltd. against Abclon Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.